Transarterial chemoembolization with medium-sized doxorubicin-eluting Callisphere is safe and effective for patients with hepatocellular carcinoma. [electronic resource]
Producer: 20201123Description: 4434 p. digitalISSN:- 2045-2322
- Adult
- Aged
- Antibiotics, Antineoplastic -- therapeutic use
- Carcinoma, Hepatocellular -- drug therapy
- Chemoembolization, Therapeutic -- methods
- Doxorubicin -- therapeutic use
- Female
- Follow-Up Studies
- Humans
- Liver Neoplasms -- drug therapy
- Male
- Microspheres
- Middle Aged
- Prognosis
- Response Evaluation Criteria in Solid Tumors
- Retrospective Studies
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.